Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia

被引：5

作者：

Ford, Martin ^{[1
,2
]}

Fishbane, Steven ^{[3
]}

Spinowitz, Bruce ^{[4
]}

Rastogi, Anjay ^{[5
]}

Guzman, Nicolas ^{[6
]}

McCafferty, Kieran ^{[7
]}

机构：

[1] Kings Coll Hosp NHS Trust, Dept Renal Med, Denmark Hill, London SE5 9RS, England

[2] Kings Coll London, Fac Life Sci & Med, London, England

[3] Zucker Sch Med Hofstra Northwell, Dept Med, Great Neck, NY USA

[4] New York Presbyterian Queens, Dept Med, Queens, NY USA

[5] Univ Calif Los Angeles, UCLA CORE Kidney Program, Los Angeles, CA USA

[6] AstraZeneca BioPharmaceut R&D, Global Med Dev, Gaithersburg, MD USA

[7] Barts Hlth NHS Trust, Dept Nephrol, London, England

来源：

KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 12期

关键词：

chronic kidney disease; hemodialysis; potassium; severe hyperkalemia; sodium zirconium cyclosilicate; DIALYSATE POTASSIUM;

D O I：

10.1016/j.ekir.2021.09.004

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3074 / 3078

页数：5

共 50 条

[31] Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia
Linder, Kristin E.
Krawczynski, Michelle A.
Laskey, Dayne
PHARMACOTHERAPY, 2016, 36 (08): : 923 - 933
[32] SODIUM ZIRCONIUM CYCLOSILICATE Potassium (K+) ion trap Treatment for hyperkalemia
Gras, J.
DRUGS OF THE FUTURE, 2015, 40 (07) : 437 - 441
[33] Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure
Kosiborod, Mikhail N.
Cherney, David Z. I.
Desai, Akshay S.
Testani, Jeffrey M.
Verma, Subodh
Chinnakondepalli, Khaja
Dolling, David
Patel, Shachi
Dahl, Magnus
Eudicone, James M.
Friberg, Lovisa
Ouwens, Mario
Antunes, Murillo O.
Connelly, Kim A.
Madrini, Vagner
Kuthi, Luca
Lala, Anuradha
Lorenzo, Miguel
Guimaraes, Patricia O.
Marcos, Marta Cobo
Merkely, Bela
Nunez, Julio
Squire, Iain
Vaclavik, Jan
Wranicz, Jerzy
Petrie, Mark C.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (10) : 971 - 984
[34] Sodium zirconium cyclosilicate for hyperkalemia: a collateral acid-base benefit?
Wesson, Donald E.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (05) : 756 - 760
[35] Comparison of Sodium Zirconium Cyclosilicate to Sodium Polystyrene Sulfonate in the Inpatient Management of Acute Hyperkalemia
Joyce, Olivia
Corpman, Michael
JOURNAL OF PHARMACY PRACTICE, 2024, 37 (03) : 728 - 735
[36] Serum potassium response to single-dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients
Lewis, Haley
Stamper, Benton
Yungkurth, Alyssa Claudio
PHARMACOTHERAPY, 2024, 44 (01): : 13 - 21
[37] Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore
Chay, Junxing
Choo, Jason C. J.
Finkelstein, Eric A.
NEPHROLOGY, 2024, 29 (05) : 278 - 287
[38] Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis NEUTRALIZE Randomized Study
Ash, Stephen R.
Batlle, Daniel
Kendrick, Jessica
Oluwatosin, Yemisi
Kooienga, Laura
Eudicone, James M.
Sundin, Anna-Karin
Guerrieri, Emily
Fried, Linda F.
KIDNEY360, 2024, 5 (06): : 812 - 820
[39] Sodium Zirconium Cyclosilicate
Levien, Terri L.
Baker, Danial E.
HOSPITAL PHARMACY, 2019, 54 (01) : 12 - 19
[40] Effect of sodium zirconium cyclosilicate in combination with insulin and glucose infusion on hyperkalemia treatment
Wu, Xuansheng
Yue, Li
Yin, Na
Dai, Feng
He, Fang
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (10) : 2217 - 2224

← 1 2 3 4 5 →